TMS uses electromagnetic induction to stimulate neurons, similar to how a wireless charger transfers energy. The FDA has cleared TMS for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder ...

Weirton, W.Va (WTRF) – Northwood Health Systems will host a virtual community information session on Transcranial Magnetic ...

LONG BEACH, CA - March 11, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...

Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...

DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Restore Brain, a multi-state interventional behavioral health practice specializing in neuromodulation, today shared new clinical insights into how ...

Moment of Clarity has released a new educational publication titled Transcranial Magnetic Stimulation in California, providing evidence-based insight into how transcranial magnetic stimulation (TMS) ...

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...